Disease research

Drug development by therapeutic area

How much development is happening in each disease area, how often drugs in that area have historically been approved, and which experimental drugs we track there.

Approval odds from BIO, Informa Pharma Intelligence, QLS Advisors (2021). The all-indication average is 7.9% from Phase 1.